Green Cross
-
Green Cross Secures Approval for Advanced Flu Vaccine Clinical Trials
South Korea’s Ministry of Food and Drug Safety has cleared Green Cross to begin Phase 2 and 3 trials for its high-immunogenicity flu vaccine candidate, GC3114B.
South Korea’s Ministry of Food and Drug Safety has cleared Green Cross to begin Phase 2 and 3 trials for its high-immunogenicity flu vaccine candidate, GC3114B.